CTI(SZ:300012) GOLDEN SUN SECURITIES·2025-08-22 13:11Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company demonstrated resilience as a market leader with steady revenue growth and improved profit quality in Q2, achieving a revenue of 2.96 billion yuan and a net profit of 470 million yuan in H1 2025, reflecting a year-on-year increase of 6% and 7% respectively [1] - The company is actively pursuing digital transformation and strategic acquisitions to enhance operational efficiency and expand its market presence [3] Summary by Sections Financial Performance - In H1 2025, the company achieved a revenue of 2.96 billion yuan, up 6% year-on-year, and a net profit of 470 million yuan, up 7% year-on-year, with a net profit margin of 15.8%, an increase of 0.14 percentage points [1] - The company reported a significant improvement in operating cash flow, with a net cash flow from operating activities of 175 million yuan, an increase of 153 million yuan compared to the same period last year [2] Business Segments - Life Sciences segment generated revenue of 1.27 billion yuan, up 1.1% year-on-year, with a gross margin of 51.2%, reflecting a 1.7 percentage point increase [2] - Industrial Testing segment achieved revenue of 600 million yuan, up 7.5% year-on-year, with a gross margin of 43.4%, down 2 percentage points [2] - Trade Assurance segment reported revenue of 430 million yuan, up 13% year-on-year, with a gross margin of 73.3%, up 0.6 percentage points [2] - Consumer Products Testing segment generated revenue of 520 million yuan, up 13% year-on-year, with a gross margin of 41.5%, down 1.8 percentage points [2] - Pharmaceutical and Medical segment achieved revenue of 140 million yuan, up 1% year-on-year, with a gross margin of 19.4%, down 5 percentage points [2] Strategic Initiatives - The company is focusing on digital transformation by establishing an AI innovation team and successfully delivering multiple AI projects to enhance operational efficiency [3] - The company has made several strategic acquisitions, including the full acquisition of Guangzhou Ausi Analysis Testing and agreements to acquire stakes in companies in the ESG field and carbon emission verification market [3] Future Projections - The company is expected to achieve net profits of 1 billion yuan, 1.1 billion yuan, and 1.2 billion yuan for the years 2025, 2026, and 2027 respectively, with an estimated EPS of 0.60 yuan, 0.66 yuan, and 0.72 yuan [3][4]